Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Patents: Applications Pending

AKEBIA THERAPEUTICS, INC. Patent Applications Pending

71 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-09-04: Application 19319408; Invention SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOF; Applicant Akebia Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
  • 2025-03-05: Application 19071033; Invention PROCESS FOR PREPARING 2-[[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO]ACETIC ACID; Applicant Akebia Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
  • 2024-12-20: Application 18991047; Invention METHODS FOR TREATING VIRAL INFECTIONS, ORGAN INJURY, AND RELATED CONDITIONS; Applicant Akebia Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
  • 2024-12-18: Application PCTUS2024060843; Invention PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE; Applicant AKEBIA THERAPEUTICS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2025-09-0419319408SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260263438A1
James Densmore Copp
Ann W. Newman
Anne Luong
United States
United States
Canada
CENTRAL, DOCKET
2025-03-0519071033PROCESS FOR PREPARING 2-[[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO]ACETIC ACIDAkebia Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250243164A1
Boris I. Gorin
Christopher M. Lanthier
Anne Buu Chau Luong
James Densmore Copp
Javier Gonzalez
Sascha Jautze
Erich Kraus
Alan O'Connor
Canada
Canada
Canada
United States
United States
United States
Germany
United States
CENTRAL, DOCKET
2024-12-2018991047METHODS FOR TREATING VIRAL INFECTIONS, ORGAN INJURY, AND RELATED CONDITIONSAkebia Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250352527A1
Steven Burke
Michael Rabinowitz
United States
United States
ROBINSON, MIKHAIL O'DONNEL
2024-12-18PCTUS2024060843PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
SENKARA RAO ALLU
PAUL E. FLEMING
United States
United States
2024-10-29PCTUS2024053402TREATMENT OF COMPLEMENT-ASSOCIATED RENAL DISEASESAKEBIA THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
JASON CAMPAGNA
SHELIA MARIE VIOLETTE
HONG WU
United States
United States
United States
THOMAS, SHANE M
2024-10-29PCTUS2024053399TREATMENT OF ANCA-ASSOCIATED VASCULITISAKEBIA THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
JASON CAMPAGNA
SHELIA MARIE VIOLETTE
HONG WU
United States
United States
United States
THOMAS, SHANE M
2024-06-1318742052SELECTIVE PHD1 INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAkebia Therapeutics, Inc.Non Final Action MailedUS20240336568A1
Thomas P. BLAISDELL
Paul E. FLEMING
United States
United States
TRAN, ERIC
2024-06-1318742035PICOLINAMIDE COMPOUNDS AS SELECTIVE PHD1 INHIBITORS, COMPOSITIONS, AND METHODS OF USEAkebia Therapeutics, Inc.Non Final Action MailedUS20240327376A1
Thomas P. BLAISDELL
Paul E. FLEMING
United States
United States
NOTTINGHAM, KYLE GREGORY
2023-12-1963612140PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAkebia Therapeutics, Inc.Provisional Application Expired
Senkara Rao Allu
Paul E. Fleming
United States
United States
2023-12-1518542100METHODS OF TREATING COMPLEMENT MEDIATED DISEASES WITH FUSION PROTEIN CONSTRUCTS COMPRISING ANTI-C3d ANTIBODY AND A COMPLEMENT MODULATORAkebia Therapeutics, IncNon Final Action MailedUS20240301043A1
Michael Steven Curtis
Michael Storek
Shelia Marie Violette
Susan L. Kalled
Kelly C. Fahnoe
Cheng Ran Huang
Ellen Garber Stark
Frederick Robbins Taylor
Justin Andrew Caravella
Vernon Michael Holers
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
SZPERKA, MICHAEL EDWARD
2023-11-0218500471Compositions and Methods for Treating AnemiaAkebia Therapeutics, Inc.Non Final Action MailedUS20240325361A1
Alexander Smith
Gurudatt Ajay Chandorkar
Ene Ikpong Ette
Bradley John Maroni
Charlotte Suzanne Hartman
Ramin Farzaneh-Far
Jula Kern Inrig
United States
United States
United States
United States
United States
United States
United States
YOO, SUN JAE
2023-08-3118279680MODULATION OF DRUG-DRUG INTERACTIONS OF VADADUSTATAkebia Therapeutics, Inc.Publications -- Issue Fee Payment VerifiedUS20240148707A1
Ajit CHAVAN
Steven BURKE
United States
United States
HENLEY III, RAYMOND J
2023-07-1818012012MANUFACTURING PROCESS FOR 3,5-DICHLOROPICOLINONITRILE FOR SYNTHESIS OF VADADUSTATAkebia Therapeutics, Inc.Notice of Allowance Mailed -- Application Received in Office of PublicationsUS20230286918A1
Valdas JURKAUSKAS
Young Chun JUNG
Taesoo KWON
Arunachalam KANNAN
Vijaya Bhasker GONDI
United States
United States
United States
United States
United States
ANDERSON, REBECCA L
2023-02-1318041490PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAkebia Therapeutics, Inc.Final Rejection MailedUS20230295110A1
Thomas P. BLAISDELL
Senkara Rao ALLU
Paul E. FLEMING
United States
United States
United States
SHIM, DAVID M.
2022-09-1917906652PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND USEAkebia Therapeutics, Inc.Patented CaseUS20230159489A1
Paul E. FLEMING
Thomas P. BLAISDELL
Senkara Rao ALLU
United States
United States
United States
WHITE, DAWANNA SHAR-DAY
2022-09-1917906650PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND USEAkebia Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20230227426A1
Paul E. FLEMING
Thomas P. BLAISDELL
Senkara Rao ALLU
United States
United States
United States
SAMSELL, RILLA MARIE
2022-02-28PCTUS2022018152MODULATION OF DRUG-DRUG INTERACTIONS OF VADADUSTATAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
STEVEN BURKE
AJIT CHAVAN
United States
United States
2022-01-07PCTUS2022011668COMPOUNDS AND COMPOSITION FOR THE TREATMENT OF ANEMIAAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
ANNA ZUK
MICHAEL RABINOWITZ
STEVEN BURKE
AJIT CHAVAN
KIP WEST
United States
United States
United States
United States
United States
2022-01-07PCTUS2022011666THERAPEUTIC METHODS USING VADADUSTATAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
ZEESHAN KHAWAJA
AJIT CHAVAN
STEVEN BURKE
United States
United States
United States
2021-10-2763272437METHODS FOR TREATING VIRAL INFECTIONS, ORGAN INJURY, AND RELATED CONDITIONSAkebia Therapeutics, Inc.Provisional Application Expired
Steven Burke
Michael Rabinowitz
United States
United States
2021-08-13PCTUS2021045896PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
PAUL E. FLEMING
SENKARA RAO ALLU
THOMAS P. BLAISDELL
United States
United States
United States
2021-07-01PCTUS2021040138MANUFACTURING PROCESS FOR 3,5-DICHLOROPICOLINONITRILE FOR SYNTHESIS OF VADADUSTATAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
TAESOO KWON
VIJAYA BHASKER GONDI
ARUNACHALAM KANNAN
VALDAS JURKAUSKAS
YOUNG CHUN JUNG
United States
United States
United States
United States
United States
2021-04-20PCTUS2021028126METHODS FOR TREATING VIRAL INFECTIONS, ORGAN INJURY, AND RELATED CONDITIONSAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
MICHAEL RABINOWITZ
STEVEN BURKE
United States
United States
2021-04-2063177104THERAPEUTIC METHODS USING VADADUSTATAkebia Therapeutics, Inc.Provisional Application Expired
Steven Burke
Ajit Chavan
Zeeshan Khawaja
United States
United States
United States
2021-04-2063177098THERAPEUTIC METHODS USING VADADUSTATAkebia Therapeutics, Inc.Provisional Application Expired
Steven Burke
Ajit Chavan
Zeeshan Khawaja
United States
United States
United States
2021-03-19PCTUS2021023228PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
THOMAS P. BLAISDELL
SENKARA RAO ALLU
PAUL E. FLEMING
United States
United States
United States
2021-03-19PCTUS2021023222PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
PAUL E. FLEMING
SENKARA RAO ALLU
THOMAS P. BLAISDELL
United States
United States
United States
2021-03-19PCTUS2021023219PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
PAUL E. FLEMING
SENKARA RAO ALLU
THOMAS P. BLAISDELL
United States
United States
United States
2021-03-0163155022MODULATION OF DRUG-DRUG INTERACTIONS OF VADADUSTATAkebia Therapeutics, Inc.Provisional Application Expired
Ajit Chavan
Steven Burke
United States
United States
2021-01-0863135327THERAPEUTIC METHODS USING VADADUSTATAKEBIA THERAPEUTICS, INC.Provisional Application Expired
Steven Burke
Ajit Chavan
Zeeshan Khawaja
United States
United States
United States
2021-01-0863135316THERAPEUTIC METHODS USING VADADUSTATAkebia Therapeutics, Inc.Provisional Application Expired
Steven Burke
Ajit Chavan
Zeeshan Khawaja
United States
United States
United States
2021-01-0863135202COMPOUNDS AND COMPOSITION FOR THE TREATMENT OF ANEMIAAkebia Therapeutics, Inc.Provisional Application Expired
Kip West
Michael Rabinowitz
Anna Zuk
Steven Burke
Ajit Chavan
United States
United States
United States
United States
United States
2020-08-1463065642PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAkebia Therapeutics, Inc.Provisional Application Expired
Thomas P. Blaisdell
Senkara Rao Allu
Paul E. Fleming
United States
United States
United States
2020-07-0263047654MANUFACTURING PROCESS FOR 3,5-DICHLOROPICOLINONITRILE FOR SYNTHESIS OF VADADUSTATAkebia Therapeutics, Inc.Provisional Application Expired
Valdas Jurkauskas
Young Chun Jung
Taesoo Kwon
Arunachalam Kannan
Vijaya Bhasker Gondi
United States
United States
Korea, Republic Of
United States
United States
2020-07-0263047501METHODS FOR TREATING VIRAL INFECTIONS, ORGAN INJURY, AND RELATED CONDITIONSAkebia Therapeutics, Inc.Provisional Application Expired
Steven Burke
Michael Rabinowitz
United States
United States
2020-05-1163022890METHODS FOR TREATING VIRAL INFECTIONS, ORGAN INJURY, AND RELATED CONDITIONSAkebia Therapeutics, Inc.Provisional Application Expired
Steven Burke
Michael Rabinowitz
United States
United States
2020-04-2063012839METHODS FOR TREATING VIRAL INFECTIONS, ORGAN INJURY, AND RELATED CONDITIONSAkebia Therapeutics, Inc.Provisional Application Expired
Steven Burke
Michael Rabinowitz
United States
2020-03-2062992616PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAkebia Therapeutics, Inc.Provisional Application Expired
Paul E. Fleming
Thomas P. Blaisdell
Senkara Rao Allu
United States
United States
United States
2020-03-2062992606PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAkebia Therapeutics, Inc.Provisional Application Expired
Paul E. Fleming
Thomas P. Blaisdell
Senkara Rao Allu
United States
United States
United States
2020-03-2062992585PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USEAkebia Therapeutics, Inc.Provisional Application Expired
Paul E. Fleming
Thomas P. Blaisdell
Senkara Rao Allu
United States
United States
United States
2019-11-1362934888SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACIDAkebia Therapeutics, Inc.Provisional Application Expired
Sudhir Ranjan
Xiaoyang Wang
United States
China
2019-05-08PCTUS2019031310PROCESS FOR PREPARING 2-[[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO]ACETIC ACIDAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
CHRISTOPHER M. LANTHIER
BORIS I. GORIN
JAVIER GONZALEZ
JAMES DENSMORE COPP
ANNE BUU CHAU LUONG
United States
United States
United States
United States
United States
2018-08-01PCTUS2018044825COMPOSITIONS AND METHODS FOR TREATMENT OF HEMOGLOBIN DISORDERSAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
RAMIN FARZANEH-FAR
EMIL MORADA DEGOMA
ANNA ZUK
United States
United States
United States
2018-05-0962669135Process for Preparing 2-[[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino] Acetic AcidAkebia Therapeutics, Inc.Provisional Application Expired
Boris I. Gorin
Christopher M. Lanthier
Anne Buu Chau Luong
James Densmore Copp
Javier Gonzalez
Canada
Canada
Canada
United States
United States
2017-08-0162539877COMPOSITIONS AND METHODS FOR TREATMENT OF HEMOGLOBIN DISORDERSAkebia Therapeutics, Inc.Provisional Application Expired
Ramin Farzaneh-Far
Anna Zuk
Emil Morada deGoma
United States
United States
United States
2016-03-31PCTUS2016025235COMPOSITIONS AND METHODS FOR TREATING ANEMIAAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JULA KERN INRIG
RAMIN FARZANEH-FAR
GURUDATT AJAY CHANDORKAR
CHARLOTTE SUZANNE HARTMAN
ALEXANDER SMITH
ENE IKPONG ETTE
BRADLEY JOHN MARONI
United States
United States
United States
United States
United States
United States
United States
THOMAS, SHANE M
2016-03-18PCTUS2016023132DEUTERIUM-ENRICHED HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE ENZYME INHIBITORSAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
ROGER HANSELMANN
United States
THOMAS, SHANE M
2016-01-22PCTUS2016014517SOLID FORMS OF 2-(5-(3-FLUOROPHENYL)-3-HYDROXYPICOLINAMIDO)ACETIC ACID, COMPOSITIONS, AND USES THEREOFAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
ROGER HANSELMANN
ANNE LUONG
United States
Canada
YOUNG, LEE W
2015-12-2162270168Compositions and Methods for Treating AnemiaAkebia Therapeutics, Inc.Provisional Application Expired
Alexander Smith
Gurudatt Ajay Chandorkar
Ene Ikpong Ette
Bradley John Maroni
Charlotte Suzanne Hartman
Ramin Farzaneh-Far
Jula Kern Inrig
United States
United States
United States
United States
United States
United States
United States
2015-08-1462205096SOLID FORMS OF 2-(5-(3-FLUOROPHENYL)-3-HYDROXYPICOLINAMIDO)ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Provisional Application Expired
Roger Hanselmann
Anne Luong
United States
Canada
2015-04-0162141420Compositions and Methods for Treating AnemiaAkebia Therapeutics, Inc.Provisional Application Expired
Alexander Smith
Gurudatt Ajay Chandorkar
Ene Ikpong Ette
Bradley John Maroni
Charlotte Suzanne Hartman
Ramin Farzaneh-Far
Jula Kern Inrig
United States
United States
United States
United States
United States
United States
United States
2015-03-2062136078DEUTERIUM-ENRICHED HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE ENZYME INHIBITORSAKEBIA THERAPEUTICS, INC.Provisional Application Expired
Roger Hanselmann
United States
2015-01-23PCTUS2015012634COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASESAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
ROBERT SHALWITZ
WILLIAM DALY
United States
United States
THOMAS, SHANE M
2015-01-2362106765SOLID FORMS OF 2-(5-(3-FLUOROPHENYL)-3-HYDROXYPICOLINAMIDO)ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Provisional Application Expired
Roger Hanselmann
Anne Luong
United States
Canada
2014-11-14PCTUS2014065631SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL] AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOFAKEBIA THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JAMES DENSMORE COPP
ANNE LUONG
ANN W. NEWMAN
United States
Canada
United States
YOUNG, LEE W
2014-06-04PCTUS2014040889COMPOSITIONS AND METHODS FOR TREATING ANEMIAAKEBIA THERAPEUTICS , INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
ROBERT SHALWITZ
CHARLOTTE HARTMAN
JOSEPH GARDNER
ISAIAH SHALWITZ
JOHN JANUSZ
AKSHAY BUCH
United States
United States
United States
United States
United States
United States
THOMAS, SHANE M
2014-01-2361930811COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASESAkebia Therapeutics, Inc.Provisional Application Expired
Robert Alan Shalwitz
William Daly
United States
United States
2013-12-0561912185PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USEAkebia Therapeutics, Inc.Provisional Application Expired
John Michael Janusz
Joseph H. Gardner
United States
United States
2013-11-1561904803SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Provisional Application Expired
James Densmore Copp
Ann W. Newman
Anne Luong
United States
United States
Canada
2013-11-0161898890COMPOSITIONS AND METHODS FOR TREATING ANEMIAAkebia Therapeutics, Inc.Provisional Application Expired
Robert Alan Shalwitz
Isaiah Shalwitz
Charlotte Suzanne Hartman
United States
United States
United States
2013-11-0161898885COMPOSITIONS AND METHODS FOR TREATING ANEMIAAkebia Therapeutics, Inc.Provisional Application Expired
Robert Alan Shalwitz
Isaiah Shalwitz
Charlotte Suzanne Hartman
United States
United States
United States
2013-10-1061889478COMPOSITIONS AND METHODS FOR TREATING ANEMIAAkebia Therapeutics, Inc.Provisional Application Expired
Robert Alan Shalwitz
Isaiah Shalwitz
Charlotte Suzanne Hartman
United States
United States
United States
2013-06-1361834808COMPOSITIONS AND METHODS FOR DOSING ORALLY ACTIVE HIF PROLYL HYDROXYLASE INHIBITORSAkebia Therapeutics, Inc.Provisional Application Expired
Robert Alan Shalwitz
Charlotte Suzanne Hartman
Akshay Bhaskarrai Buch
United States
United States
United States
2012-06-05PCTUS2012040945COMPOUNDS AND COMPOSITIONS FOR STABILIZING HYPOXIA INDUCIBLE FACTOR-2 ALPHA AS A METHOD FOR TREATING CANCERAKEBIA THERAPEUTICS INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JOHN M. JANUSZ
JOSEPH H. GARDNER
ROBERT SHALWITZ
United States
United States
United States
YOUNG, LEE W
2012-06-05PCTUS2012040942METHODS FOR STABILIZING HYPOXIA INDUCIBLE FACTOR-2 ALPHA AS A METHOD FOR TREATING CANCERAKEBIA THERAPEUTICS INC
THE OHIO STATE UNIVERSITY
RO PROCESSING COMPLETED-PLACED IN STORAGE
CLAY B. MARSH
TIMOTHY DARREN EUBANK
ROBERT SHWLWITZ
JOSEPH M GARDNER
JULIE MICHELLE RODA
United States
United States
United States
United States
United States
YOUNG, LEE W
2012-06-05PCTUS2012040833PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDESAKEBIA THERAPEUTICS INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JAN OUDENES
CRAIG EDWARD DIXON
BORIS GORIN
JAMES DENSMORE COPP
ALAN QUIGBO LU
JOHN MICHAEL JANUSZ
CHRISTOPHER M. LANTHIER
Canada
Canada
Canada
United States
Canada
United States
Canada
YOUNG, LEE W
2010-01-12PCTUS2010020822COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLSAKEBIA THERAPEUTICS INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
KEVIN GENE PETERS
ROBERT SHALWITZ
United States
YOUNG, LEE W
2010-01-12PCTUS2010020817METHODS FOR TREATING VASCULAR LEAK SYNDROMEAKEBIA THERAPEUTICS INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
ROBERT SHALWITZ
United States
YOUNG, LEE W
19582939TREATMENT OF COMPLEMENT-ASSOCIATED RENAL DISEASESAkebia Therapeutics, inc.Application Undergoing Preexam Processing
Jason Campagna
Shelia Marie Violette
Hong Wu
United States
United States
United States
19582937TREATMENT OF ANCA-ASSOCIATED VASCULITISAkebia Therapeutics, IncApplication Undergoing Preexam Processing
Jason Campagna
Shelia Marie Violette
Hong Wu
United States
United States
United States
19501328TARGETED TREATMENT OF COMPLEMENT-MEDIATED DISEASE THROUGH LOCAL COMPLEMENT INHIBITION BASED ON URINARY uC5b-9 DETECTIONAKEBIA THERAPEUTICS, INC.Application Undergoing Preexam Processing
Stefan Wawersik
Shelia Marie Violette
Jennifer Morgan
Sarah Ryan
Claire Galand
Joshua M. Thurman
United States
United States
United States
United States
United States
United States

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33